MedPath

In-vivo Bioequivalence Test of Ibuprofen tablet 800 mg Mofid Pharma with brand drug (Nexium ® 10 mg Sachet, AstraZeneca, UK)

Not Applicable
Recruiting
Conditions
Plasma drug concentration.
Registration Number
IRCT20200105046010N71
Lead Sponsor
Teb Mofid Nikan Pharmaceutical Co.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

General health
Body mass index between18-28
Informed consent
Being at the age of 18-55 years old

Exclusion Criteria

Smoking
A history of cardiovascular disease
A history of liver & kidney disease
Pregnancy
Alcohol & Drug addiction
Hypersensitivity to the drug

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.